4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-14-058292
Director sold 41,500 shares at $0.23 ($9,358)
- Director acquired 41,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2014-09-25 | Option exercise | +41,500 | $0.04 | $1,453 | 1,435,131 | D: show line 1 in the form |
| Kraus Al Director | 2014-09-25 | Sale | −41,500 | $0.23 | $9,358 | 1,393,631 | D: show line 2 in the form |
| Open-market sales · 41,500 sh · avg $0.23 · $9,358 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2014-09-25 | Option exercise · Stock Option | −41,500 | 6,169,328 | D: show line 3 in the form |
Loading xslF345X03/v390227_4.xml…